By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


Start Up

Company News
XBiotech USA (XBIT) To Present Pivotal Phase III Data On Xilonix At European Society Of Medical Oncology’s World Congress On Gastrointestinal Cancer 4/19/2016 7:57:20 AM
European Medicines Agency Grants Accelerated Assessment Of Marketing Authorization Application For Xilonix, XBiotech USA (XBIT)h’s True Human Therapeutic Antibody Treatment For Advanced Colorectal Cancer 4/4/2016 8:17:07 AM
Xbiotech To Deliver Presentation On Novel Study Design And Phase III Results From European Study On Xilonix During Meeting At The European Parliament 3/2/2016 7:48:38 AM
XBiotech USA (XBIT) Engages In Research For Heart Attack Antibody Therapy 2/19/2016 11:08:03 AM
Xbiotech Announces Agreement With The NCIC Clinical Trials Group To Collaborate On Phase II Study In Non-Small Cell Lung Cancer (NSCLC) 12/11/2015 7:11:42 AM
Xbiotech Announces Positive Results In European Phase III Study For Its Breakthrough Therapy For Colorectal Cancer 12/7/2015 7:44:27 AM
Xbiotech Added To The MSCI US Small Cap 1750 And The MSCI Investable Market 2500 Indexes 11/20/2015 7:58:12 AM
XBiotech Provides Third Quarter 2015 Corporate And Clinical Update 11/12/2015 8:15:34 AM
Xbiotech Identifies Positive Donors For Anti-Clostridium Difficile Therapeutic Antibody Only Two Weeks After Initial Screening 11/11/2015 7:21:12 AM
Xbiotech Announces Positive Results For Its Anti-Ebola Therapeutic Candidates Following Evaluation By USAMRIID 11/9/2015 7:40:17 AM